European Drugmakers Ask to Defer Disclosure of Trial Information

Clinical Trials Advisor
A A
The UK BioIndustry Association and EuropaBio are calling on European regulators to defer plans to report Phase I clinical trial reports, saying the information they contain is commercially sensitive.

To View This Article:

Login

Subscribe To Clinical Trials Advisor